We are live on
!
Find out more
Carmignac Gestion Portfolio holdings
AUM
$7.71B
Turnover
49.25%
1-Year Est. Return
4.02%
This Fund
S&P 500
This Quarter
Est. Return
-9.78%
1 Year Est. Return
+4.02%
3 Year Est. Return
+85.13%
5 Year Est. Return
+112.24%
10 Year Est. Return
+570.29%
AUM
$6.51B
AUM Growth
-$887M
(-12%)
Cap. Flow
-$36.2M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
55.22%
Holding
150
New
31
Increased
31
Reduced
39
Closed
42
Avg Time Held
2
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mercado Libre
MELI
|
+$208M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$200M |
| 3 |
NVIDIA
NVDA
|
+$171M |
| 4 |
Atlassian
TEAM
|
+$138M |
| 5 |
Broadcom
AVGO
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$354M |
| 2 |
SLB Ltd
SLB
|
+$181M |
| 3 |
Accenture
ACN
|
+$123M |
| 4 |
Colgate-Palmolive
CL
|
+$81.7M |
| 5 |
Equifax
EFX
|
+$76.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.01% |
| 2 | Financials | 21.07% |
| 3 | Healthcare | 17.56% |
| 4 | Consumer Discretionary | 15.56% |
| 5 | Communication Services | 7.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Procter & Gamble
PG
$365B
| $12.7M | 0.2% |
88,160
-258,332
| -75% | -$39.2M |
2021 Q4
17 quarters
|
|
52
DELISTED
Cantaloupe
CTLP
| $11.6M | 0.18% |
1,075,505
+98,347
| +10% | +$1.04M |
2025 Q2
3 quarters
|
|
53
DELISTED
Masimo
MASI
| $11.5M | 0.18% |
+64,831
| New | +$10.2M |
2026 Q1
0 quarters
|
|
54
DELISTED
Amicus Therapeutics
FOLD
| $11.3M | 0.17% |
784,508
+589,621
| +303% | +$8.45M |
2025 Q4
1 quarter
|
|
55
Home Depot
HD
$308B
| $10.1M | 0.15% |
30,734
-11,312
| -27% | -$4.12M |
2022 Q3
14 quarters
|
|
56
DELISTED
Electronic Arts
EA
| $9.98M | 0.15% |
48,934
+20,194
| +70% | +$4.08M |
2025 Q3
2 quarters
|
|
57
BioNTech
BNTX
$22.7B
| $9.96M | 0.15% |
112,711
-31,376
| -22% | -$3.22M |
2024 Q2
7 quarters
|
|
|
OS
58
DELISTED
OneStream Inc
OS
| $9.24M | 0.14% |
+384,893
| New | +$9.03M |
2026 Q1
0 quarters
|
|
59
Church & Dwight Co
CHD
$24.5B
| $9.07M | 0.14% |
+97,086
| New | +$9.33M |
2026 Q1
0 quarters
|
|
60
DELISTED
CSG Systems International
CSGS
| $8.24M | 0.13% |
103,097
| – | – |
2025 Q4
1 quarter
|
|
61
Thermo Fisher Scientific
TMO
$258B
| $7.74M | 0.12% |
15,828
-124,209
| -89% | -$67.4M |
2019 Q2
27 quarters
|
|
62
DELISTED
Janus Henderson
JHG
| $7.05M | 0.11% |
137,300
+50,001
| +57% | +$2.48M |
2025 Q4
1 quarter
|
|
63
Astera Labs
ALAB
$52.4B
| $6.58M | 0.1% |
+60,000
| New | +$8.55M |
2026 Q1
0 quarters
|
|
64
DELISTED
Warner Bros
WBD
| $6.49M | 0.1% |
236,373
+50,418
| +27% | +$1.41M |
2025 Q4
1 quarter
|
|
65
Silicon Laboratories
SLAB
$7.38B
| $5.8M | 0.09% |
+27,843
| New | +$5.11M |
2026 Q1
0 quarters
|
|
66
DELISTED
DigitalBridge
DBRG
| $5.7M | 0.09% |
+369,415
| New | +$5.69M |
2026 Q1
0 quarters
|
|
67
DELISTED
ProAssurance
PRA
| $5.37M | 0.08% |
217,263
| – | – |
2025 Q1
4 quarters
|
|
68
Micron Technology
MU
$1.05T
| $5.07M | 0.08% |
+15,000
| New | +$5.88M |
2026 Q1
0 quarters
|
|
69
DELISTED
American Woodmark
AMWD
| $4.59M | 0.07% |
115,255
| – | – |
2025 Q3
2 quarters
|
|
70
Ionis Pharmaceuticals
IONS
$7.33B
| $3.98M | 0.06% |
+53,000
| New | +$4.18M |
2026 Q1
0 quarters
|
|
71
BBB Foods
TBBB
$6.76B
| $3.78M | 0.06% |
+106,965
| New | +$3.74M |
2026 Q1
0 quarters
|
|
72
DELISTED
Semrush
SEMR
| $3.66M | 0.06% |
+306,262
| New | +$3.64M |
2026 Q1
0 quarters
|
|
73
DELISTED
Select Medical
SEM
| $2.84M | 0.04% |
+174,516
| New | +$2.73M |
2026 Q1
0 quarters
|
|
74
Keysight
KEYS
$58.2B
| $2.82M | 0.04% |
10,000
-203,000
| -95% | -$50.9M |
2024 Q2
7 quarters
|
|
75
DELISTED
Terns Pharmaceuticals
TERN
| $2.82M | 0.04% |
+53,541
| New | +$2.2M |
2026 Q1
0 quarters
|
|
Similar funds
Carmignac Gestion's Q1 2026 Portfolio in Review
As of Q1 2026, Carmignac Gestion held 150 positions worth $6.51B, down 12% from $7.39B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Carmignac Gestion's Q1 2026 filing shows 31 new, 31 increased, 39 reduced and 42 closed positions. Its largest new stake was Berkshire Hathaway Class B: 407,702 shares worth $195M. The largest sale was Microsoft, an estimated $354M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 38% a quarter earlier, followed by Financials and Healthcare.
- Carmignac Gestion's largest Q1 2026 buy was Berkshire Hathaway Class B: 407,702 shares worth $195M.
- Carmignac Gestion added most to Mercado Libre in Q1 2026, an estimated $208M increase.
- Carmignac Gestion's biggest Q1 2026 reduction was Microsoft, cutting an estimated $354M.
- Carmignac Gestion fully exited Novo Nordisk in Q1 2026, selling an estimated $51M.
- Carmignac Gestion's ten largest holdings make up 55% of its $6.51B portfolio in Q1 2026.
- Carmignac Gestion opened 31 new positions and closed 42 in Q1 2026.
- Carmignac Gestion's portfolio value fell 12% quarter-over-quarter to $6.51B.
Based on Carmignac Gestion's 13F filing for Q1 2026, filed 15 Jun 2026.